Lilly to buy three vaccine developers for nearly $4 billion in infectious disease push - Reuters
Lilly to buy three vaccine developers for nearly $4 billion in infectious disease push Reuters Exclusive | Lilly Agrees to Buy Trio of Vaccine Developers WSJ Lilly announces three acquisitions to build infectious disease portfolio | Eli Lilly and Company investor.lilly.com Three vaccine biotechs to be bought by Lilly for up to $3.8B Endpoints News Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals CNBC
YesNo saves this item as an on-site live signal so search users can understand how it connects to prediction markets and incubation topics.
If later reporting creates a clear deadline, official source, or verifiable outcome, the public event can become a tradable Yes/No question.
This item has a verifiable event angle that can be monitored for a Yes/No prediction market.